Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Perfusion Disorders”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT00062933
What this trial is testing

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03089840
What this trial is testing

Normothermic Liver Preservation Trial

Who this might be right for
End Stage Liver DiseaseLiver Diseases
University of Alberta 106
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Post-approval studies (Phase 4)Study completedNCT02472249
What this trial is testing

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 10
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00001587
What this trial is testing

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Who this might be right for
Liver NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04283890
What this trial is testing

PHP and Immunotherapy in Metastasized UM

Who this might be right for
Uveal Melanoma, Metastatic
Leiden University Medical Center 83
Testing effectiveness (Phase 2)Looking for participantsNCT07276386
What this trial is testing

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute 18
Not applicableStudy completedNCT01499979
What this trial is testing

Hypothermic Perfusion During Hemihepatectomy

Who this might be right for
Hepatic Ischemia-reperfusion Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22
Not applicableStudy completedNCT07075562
What this trial is testing

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 180
Early research (Phase 1)Study completedNCT04463368
What this trial is testing

Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases

Who this might be right for
Uveal MelanomaLiver Metastases
Vastra Gotaland Region 18
Large-scale testing (Phase 3)Study completedNCT02678572
What this trial is testing

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Who this might be right for
Melanoma, Ocular
Delcath Systems Inc. 102
Not applicableNot Yet RecruitingNCT03946852
What this trial is testing

Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation

Who this might be right for
Liver Transplant; ComplicationsIschemia Reperfusion InjuryCirrhosis+3 more
London Health Sciences Centre 20
Not applicableEnded earlyNCT00820456
What this trial is testing

Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI

Who this might be right for
Colorectal NeoplasmHepatic Neoplasm
American College of Radiology 6
Not applicableEnrolling By InvitationNCT06816212
What this trial is testing

Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions

Who this might be right for
Hepatic Malignant TumorsHepatic Perfusion Disorders
Second Affiliated Hospital, School of Medicine, Zhejiang University 280
Testing effectiveness (Phase 2)Looking for participantsNCT07281924
What this trial is testing

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Who this might be right for
Metastatic MelanomaLiver Metastases
University of Wisconsin, Madison 15
Not applicableEnded earlyNCT01163526
What this trial is testing

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Who this might be right for
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal Cancer+4 more
Stanford University 13
Not applicableStudy completedNCT03864497
What this trial is testing

Myocardial Perfusion Imaging in Liver Transplantation Candidates

Who this might be right for
Myocardial Perfusion ImagingLiver Failure
University Hospital Birmingham NHS Foundation Trust 403
Load More Results